Citius Oncology (CTOR) Other Accumulated Expenses (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Other Accumulated Expenses of $8.2 million for Q1 2026, up 66.37% year-over-year from $4.9 million in Q1 2025, and down 28.48% quarter-over-quarter from $11.5 million in Q4 2025.
Citius Oncology (CTOR) Other Accumulated Expenses (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Other Accumulated Expenses for 4 consecutive years, with $8.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Accumulated Expenses rose 66.37% year-over-year to $8.2 million; the TTM figure through Mar 2026 stood at $8.2 million (up 66.37% YoY), while the FY2025 annual figure was $9.5 million, up 1515.77% from the prior year.
- Other Accumulated Expenses fell to $8.2 million in Q1 2026 per CTOR's latest filing, from $11.5 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $19.5 million in Q3 2023 and bottomed at $344875.0 in Q4 2023.
- Historically, Other Accumulated Expenses has averaged $5.6 million across 4 years, with a median of $3.9 million in 2024.
- Annual changes were most pronounced in 2024 — Other Accumulated Expenses tumbled 96.98% — and 2025, when it jumped 1515.77%.
- Citius Oncology's Other Accumulated Expenses stood at $344875.0 in 2023, then soared by 739.82% to $2.9 million in 2024, then surged by 296.87% to $11.5 million in 2025, then dropped by 28.48% to $8.2 million in 2026.
- Business Quant data shows CTOR's Other Accumulated Expenses at $8.2 million in Q1 2026, $11.5 million in Q4 2025, and $9.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Citius Oncology | 80.25 Mn | 80.25 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.22 Mn |
| Dec 31, 2025 | 11.49 Mn |
| Sep 30, 2025 | 9.51 Mn |
| Jun 30, 2025 | 7.46 Mn |
| Mar 31, 2025 | 4.94 Mn |
| Dec 31, 2024 | 2.90 Mn |
| Sep 30, 2024 | 588,806.00 |
| Jun 30, 2024 | 870,186.00 |
| Mar 31, 2024 | 537,149.00 |
| Dec 31, 2023 | 344,875.00 |
| Sep 30, 2023 | 19.50 Mn |
| Jun 30, 2023 | 349,975.00 |